期刊文献+

胰岛素制剂的安全使用 被引量:7

Safe Use of Insulin Preparations
暂未订购
导出
摘要 目的:加强我院胰岛素制剂的安全管理,促进我院胰岛素制剂的合理使用。方法:分析总结胰岛素制剂贮藏、处方和使用等环节中存在的安全隐患和潜在问题,针对以上各环节对医师、药师、护理人员及患者进行干预。结果及结论:提高了我院胰岛素制剂的管理水平,保障了胰岛素制剂的安全使用,预防了不良事件的发生。 OBJECTIVE:To strengthen safe management on insulin preparations so as to promote rational use o insulin preparations in our hospital.METHODS:The safety loopholes and the potential hidden problems in th storage,prescription and use of insulin were analyzed,and interventions on the behaviors of physicians,pharmacists nurses and patients were taken accordingly.RESULTS CONCLUSION:The management level of insulin preparation has been enhanced which thus ensured the quality and safety of insulin preparations and prevented the occurrence o adverse events in our hospital.
出处 《中国医院用药评价与分析》 2010年第8期763-765,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 胰岛素 安全 合理使用 管理措施 临床干预 Insulin Safety Rational use Management measures Clinical intervention
  • 相关文献

参考文献11

  • 1Vimalavathini R, Gitanjali B. Effect of temperature on the potency & pharmacological action of insulin [J]. Indian J Med Res, 2009, 130 (8) : 166.
  • 2任伶俐,李隆珍,胡定伟.胰岛素使用安全隐患及其对策[J].解放军护理杂志,2009,26(7):57-58. 被引量:10
  • 3Athanikar N, Boyer B, Deamer R, et al. Visual compatibility of 30 additives with a parenteral nutrient solution [J]. Am J Hosp Pharm, 1979, 36: 511.
  • 4Trissel LA, Xu QA, Baker M. Drug compatibility with new polyolefin infusion solution containers [ J ]. Am J Health - Syst Pharm , 2006, 63 : 2379.
  • 5Lim SCB, Roberts M J, Paech M J, et al. Stability of infusion aspart in normal saline infusion [ J]. J Pharm Pract Res, 2004, 34 : 11.
  • 6Dasta JF, Hale KN, Stauffer GL, et al. Comparison of visual and turbidimetric methods for determining short - term compatibility of intravenous critical - care drugs [J]. Am J Hosp Pharm, 1988, 45: 2361.
  • 7Schuetz DH, King JC. Compatibility and stability of electrolytes, vitamins and antibiotics in combination with 8% amino acids solution [J]. Am J Hosp Pharm, 1978, 35 : 33.
  • 8Lawrence AT. Handbook on Injectable Drugs [ M ]. Made : American Society of Health - System Pharmacists, 2009 : 914 - 917.
  • 9Grajower MM, Fraser CG, Holcombe JH, et al. How long should insulin be used once a vial is started [ J] ? Diabetes Care, 2003, 26 (9) : 2665.
  • 10Gallo M, Monge L, Comoglio M, et al. Insulin Storage in Europe: a comment to Grajower et al. , Eli Lilly, and Novo Nordisk [J]. Diabetes Care, 2004, 27(5): 1225.

二级参考文献14

共引文献31

同被引文献53

  • 1母义明,陈康.糖尿病强化治疗的地位和作用[J].中国医学前沿杂志(电子版),2012,4(3):1-4. 被引量:4
  • 2孙子林,鞠昌萍,叶秀利.2011中国糖尿病患者胰岛素使用教育管理规范解读[J].中国医学前沿杂志(电子版),2012,4(3):54-57. 被引量:37
  • 3李武平,宋向阳,刘田,刘冰.胰岛素注射液启封后无菌保存期及药物活性的探讨[J].解放军护理杂志,2007,24(6):21-22. 被引量:23
  • 4中华人民共和国卫生部.消毒基数规范[M].北京:卫生部卫生法制与监督司,2002:197-198.
  • 5.医院感染管理规范(试行)[S].[S].北京:中华人民共和国卫生部,2000.4-6.
  • 6万静波.提高临床护士安全注射胰岛素的对策[J].临床护理,2011.9(24):336-338.
  • 7Harris MI, Eastman RC, Cowie CC, et al. Racial and ethnic differ-ences in glycemic control in adults with type 2 diabetes [J]. Dlabetes Care,1999(22):403-408.
  • 8Turner RC, Cull CA, Frighi V, et al. Glycemic control with diet, sul-fortylurea, mefformin,or insulin in patients with type 2 diabetes melli-tus:progressive requirement for multiple therapies (UKPDS 49) [J]. JAMA, 1999(281):2005-2012.
  • 9Yang WY, Lu JM, Weng JP, et al . Prevalence of Diabetes among Men and Women in China[J]. N Engl J Med. 2010(12):1090-1101.
  • 10Rosenstock J, Daileyg, Massi-Benedetti M, et al. Reducedhy poglyce-mia risk with insulin glargine a meta-analysis comparing insulin glargine with human NPH insulin in type 2diabetes [J]. Diabetes Care,2005,28(4):950-955.

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部